Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598–606.

Article  PubMed  PubMed Central  Google Scholar 

Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy†. Hepatology. 2009;49.

Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, et al. GP73, a novel golgi-localized protein upregulated by viral infection. Gene. 2000;249:53–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology. 2002;35:1431–40.

Article  CAS  PubMed  Google Scholar 

Atilla A, Taskin MH, Kazak Z, Aydin S, Kilic SS. GP73 level in patients with chronic hepatitis B: relationship with liver biopsy, levels of ALT, AST and HBV DNA. Indian J Pathol Microbiol. 2022;65:55–8.

PubMed  Google Scholar 

Gatselis NK, Tornai T, Shums Z, Zachou K, Saitis A, Gabeta S, et al. Golgi protein-73: a biomarker for assessing cirrhosis and prognosis of liver disease patients. World J Gastroenterol. 2020;26:5130–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu Y, Chen W, Zhao Y, Chen L, Peng T. Quantitative analysis of elevated serum golgi protein-73 expression in patients with liver diseases. Ann Clin Biochem. 2009;46:38–43.

Article  CAS  PubMed  Google Scholar 

Li Y, Yang Y, Li Y, Zhang P, Ge G, Jin J, et al. Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis. J Int Med Res. 2021;49:3000605211055378.

Article  CAS  PubMed  Google Scholar 

Liu X, Wan X, Li Z, Lin C, Zhan Y, Lu X. Golgi protein 73(GP73), a useful serum marker in liver diseases. Clin Chem Lab Med. 2011;49:1311–6.

Article  CAS  PubMed  Google Scholar 

Wei H, Li B, Zhang R, Hao X, Huang Y, Qiao Y, et al. Serum GP73, a marker for evaluating progression in patients with chronic HBV infections. PLoS ONE. 2013;8:e53862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei H, Zhang J, Li H, Ren H, Hao X, Huang Y. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections. Diagn Microbiol Infect Dis. 2014;79:19–24.

Article  CAS  PubMed  Google Scholar 

Wei M, Xu Z, Pan X, Zhang X, Liu L, Yang B, et al. Serum GP73 - an additional biochemical marker for liver inflammation in chronic HBV infected patients with normal or slightly raised ALT. Sci Rep. 2019;9:1170.

Article  PubMed  PubMed Central  Google Scholar 

Xu Z, Liu L, Pan X, Wei K, Wei M, Liu L, et al. Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease. Med (Baltim). 2015;94:e659.

Article  CAS  Google Scholar 

Yao M, Wang L, You H, Wang J, Liao H, Yang D, et al. Serum GP73 combined AST and GGT reflects moderate to severe liver inflammation in chronic hepatitis B. Clin Chim Acta. 2019;493:92–7.

Article  CAS  PubMed  Google Scholar 

Morota K, Nakagawa M, Sekiya R, Hemken PM, Sokoll LJ, Elliott D, et al. A comparative evaluation of golgi protein-73, fucosylated hemopexin, alpha-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Clin Chem Lab Med. 2011;49:711–8.

Article  CAS  PubMed  Google Scholar 

Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, et al. A new nomenclature for the laminins. Matrix Biol. 1994;14:209–11.

Article  CAS  PubMed  Google Scholar 

Giannelli G, Fransvea E, Bergamini C, Marinosci F, Antonaci S. Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma. Clin Cancer Res. 2003;9:3684–91.

CAS  PubMed  Google Scholar 

Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004;20:255–84.

Article  CAS  PubMed  Google Scholar 

Yurchenco PD. Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol. 2011;3.

Koshikawa N, Moriyama K, Takamura H, Mizushima H, Nagashima Y, Yanoma S, et al. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells. Cancer Res. 1999;59:5596–601.

CAS  PubMed  Google Scholar 

Scialpi R, Arrè V, Giannelli G, Dituri F. Laminin-332 γ2 monomeric chain promotes adhesion and migration of hepatocellular carcinoma cells. Cancers (Basel). 2023;15.

Chen J, Zhang H, Luo J, Wu X, Li X, Zhao X, et al. Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma. Oncol Lett. 2018;16:199–210.

PubMed  PubMed Central  Google Scholar 

Ogawa T, Tsubota Y, Hashimoto J, Kariya Y, Miyazaki K. The short arm of laminin gamma2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta4 chain. Mol Biol Cell. 2007;18:1621–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kiyokawa H, Yasuda H, Oikawa R, Okuse C, Matsumoto N, Ikeda H, et al. Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinoma. Cancer Sci. 2017;108:1432–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamashita T, Koshikawa N, Shimakami T, Terashima T, Nakagawa M, Nio K, et al. Serum laminin γ2 Monomer as a diagnostic and predictive biomarker for hepatocellular carcinoma. Hepatology. 2021;74:760–75.

Article  CAS  PubMed  Google Scholar 

Hemken PM, Sokoll LJ, Yang X, Dai J, Elliott D, Gawel SH, et al. Validation of a novel model for the early detection of hepatocellular carcinoma. Clin Proteom. 2019;16:2.

Article  Google Scholar 

Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, et al. Validation of the GALAD model and establishment of GAAP model for diagnosis of hepatocellular carcinoma in Chinese patients. J Hepatocell Carcinoma. 2020;7:219–32.

Article  PubMed  PubMed Central  Google Scholar 

Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009;137:110–8.

Article  CAS  PubMed  Google Scholar 

Yang T, Xing H, Wang G, Wang N, Liu M, Yan C, et al. A novel online calculator based on serum biomarkers to detect hepatocellular carcinoma among patients with hepatitis B. Clin Chem. 2019;65:1543–53.

Article  CAS  PubMed  Google Scholar 

Israeli E, Okura H, Kreutz B, Piktel R, Hadji A, Tu B, et al. Development of a new automated IL-6 immunoassay. J Immunol Methods. 2022;504:113262.

Article  CAS  PubMed  Google Scholar 

Koshikawa N, Minegishi T, Sharabi A, Quaranta V, Seiki M. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain. J Biol Chem. 2005;280:88–93.

Article  CAS  PubMed  Google Scholar 

Morota K, Komori M, Fujinami R, Yamada K, Kuribayashi K, Watanabe N, et al. Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoprotein. Int J Biol Markers. 2012;27:39–46.

Article  CAS  PubMed  Google Scholar 

Fujita K, Kinukawa H, Ohno K, Ito Y, Saegusa H, Yoshimura T. Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II. Clin Biochem. 2015;48:1330–6.

Article  CAS  PubMed  Google Scholar 

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.

Article  CAS  PubMed  Google Scholar 

Hinkson A, Lally H, Gibson H, Jones R, Rowe IA, Shinkins B, et al. Meta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases. Aliment Pharmacol Ther. 2023;57:750–62.

Article  PubMed  Google Scholar 

Tangvoraphonkchai K, Suttichaimongkol T, Kularbkaew C, Sangaimwibool P, Sukeepaisarnjaroen W. Diagnostic performance of Fibrotest/Actitest for staging significant liver fibrosis in Thai chronic hepatitis C patients. J Med Assoc Thai. 2020;103:68–72.

Article  Google Scholar 

Salkic NN, Jovanovic P, Hauser G, Brcic M. FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis. Am J Gastroenterol. 2014;109:796–809.

Article  PubMed  Google Scholar 

Van Dijk A-M, Vali Y, Mak AL, Lee J, Tushuizen ME, Zafarmand MH, et al. Systematic review with meta-analyses: diagnostic accuracy of FibroMeter tests in patients with non-alcoholic fatty liver disease. J Clin Med. 2021;10:2910.

Article  PubMed  PubMed Central  Google Scholar 

Zachou K, Lygoura V, Arvaniti P, Giannoulis G, Gatselis NK, Koukoulis GK et al. FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases. Ann Hepatol. 2021;22.

Sanyal AJ, Foucquier J, Younossi ZM, Harrison SA, Newsome PN, Chan WK, et al. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based agile s